To further demonstrate ccRCC addiction to PML expression, we exploited PML targetability with ATO in ccRCC models, including cell lines and a PDX-derived cellular model (Elias et al, 2021; Chen et al, 2016). This evidence concerns the gene PML and nonpapillary renal cell carcinoma.